PositoAI/ US/ Cingulate Inc.

Cingulate Inc.

NasdaqCM: CING · Healthcare

Positivity Index

#2,489 / 6,774

Global

#809 / 4,000

United States

Positivity Score

21,459

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

Cingulate Inc. — Overview & Financial Snapshot

Cingulate Inc. (NasdaqCM: CING) is a Healthcare company, ranked #2,489 of 6,774 companies globally and #809 of 4,000 in United States on PositoAI, with a Positivity Score of 21,459. Its market capitalisation is ₹639.64 Cr ($67.76M), P/E ratio is -1.3 and P/B ratio is 2.89. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.

P/B Ratio 2.89

P/E Ratio -1.3

D/E Ratio 0.27

ROE -198.74%

Owes vs Owns ? 0.29× Low $0.29 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-331.31$-3.51

Forward EPS ₹-83.06$-0.88

Beta -0.88

Market Cap ₹639.64 Cr$67.76M

What these numbers mean →

What does Cingulate Inc. do?

What is Cingulate Inc.'s P/E and P/B ratio?

Cingulate Inc. has a P/E ratio of -1.3 and a P/B ratio of 2.89.

What is Cingulate Inc.'s debt-to-equity ratio?

Cingulate Inc. has a debt-to-equity ratio of 0.27.

How much does Cingulate Inc. owe compared with what it owns?

Cingulate Inc. owes $0.29 for every $1 it owns (balance sheet Jun 2026), which is low.

What is Cingulate Inc.'s Positivity rank?

Cingulate Inc. is ranked #2,489 of 6,774 companies globally and #809 of 4,000 in United States on PositoAI, with a Positivity Score of 21,459.

Does Cingulate Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Cingulate Inc..

Where can I read the latest news about Cingulate Inc.?

Recent headlines about Cingulate Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Cingulate Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Cingulate Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.